Medtronic: Riding On Next-Gen Tech Medical Devices

Medtronic (MDT) Buy rating: cardiovascular device leadership, FY2026 revenue +8.4% and FY2027 7% growth guide.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: SeekingAlpha